For our friends in China, we kindly suggest the following sessions at this year's annual meeting in Boston, MA.
Global Clinical Trials: The Role of Emerging Markets
What are the areas of potential risks when undertaking global clinical trials in emerging markets?
Convergence in Regulatory Science Across the Strait
What are areas of convergence in regulatory science between CDE-China and CDE-Taiwan?
GCPs in Emerging Countries
What are the GCP quality trends in US and emerging countries?
Pharmacovigilance Update for Japan, Developing Asia and Latin America
What are latest developments in pharmacovigilance in the developing countries of Asia and Latin America?
A Regulatory Perspective of Biosimilars in Emerging Markets
What are similarities/differences in biosimilar regulatory requirements in APAC and Latin America?
Global Clinical Trials: The Role of Emerging Markets
What are the areas of potential risks when undertaking global clinical trials in emerging markets?
Convergence in Regulatory Science Across the Strait
What are areas of convergence in regulatory science between CDE-China and CDE-Taiwan?
GCPs in Emerging Countries
What are the GCP quality trends in US and emerging countries?
Pharmacovigilance Update for Japan, Developing Asia and Latin America
What are latest developments in pharmacovigilance in the developing countries of Asia and Latin America?
A Regulatory Perspective of Biosimilars in Emerging Markets
What are similarities/differences in biosimilar regulatory requirements in APAC and Latin America?
Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.
No comments:
Post a Comment